Search results
Found 10540 matches for
A team of international researchers, including scientists at the MRC Molecular Haematology Unit, report promising results from a phase I clinical trial of Enasidenib, a novel drug that may help patients suffering from Acute Myeloid Leukaemia.
Study with us
Find out more about our 4 year PhD studentships.
Your Rights
Your rights under the General Data Protection Regulation